To identify the predictors for good, intermediate and poor treatment outcome in cardiac sarcoidosis.
Not Applicable
- Conditions
- Health Condition 1: null- Cardiac Sarcoidosis
- Registration Number
- CTRI/2018/05/013646
- Lead Sponsor
- CARE HOSPITALS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age >18 Years
2. Tissue proven diagnosis of non-sarcoid granuloma (node/ myocardial)
Exclusion Criteria
1.Other causes of granulomatous myocarditis- e.g. Myocardial TB (positive for TB PCR, caseating granuloma, AFB culture, pulmonary TB)
2.VT related to extensive scar to be excluded (as these scar related VT are not expected to improve with anti-inflammatory therapy in contrast to inflammatory VT)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method various clinical and imaging parameters assessed between the three groups Good, Poor and IntermediateTimepoint: 3 Months and 6 Months
- Secondary Outcome Measures
Name Time Method Serological parameters messured in the three groups.Timepoint: 3 Months and 6 Months